Company intelligence / Profile preview

Arthur Grp

Jiaxing, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Arthur Group is a high-tech innovative pharmaceutical technology enterprise focusing on the development, production, and sales of high-end drugs. Founded in 2020, the company operates R&D centers in both Jiaxing, China, and Princeton, New Jersey. Arthur Group specializes in high-end formulations, including tablets, capsules, and injectables, with a strategic focus on oncology and complex generics. The company is a pioneer in continuous manufacturing technology in China and aims to be the first domestic firm to file an FDA application for this process. Through partnerships and internal development, Arthur Group maintains a robust pipeline of optimized therapeutic agents.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Small molecule
Industry: Biotech

Partnerships

Avecho Biotechnology

Beyond the preview

Go deeper on Arthur Grp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arthur Grp.

Explore the full profile